Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-24

Clinical Trial Update: Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating hyperbaric oxygen therapy to improve cognitive deficits after surgical removal of a low-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Post Low Grade Glioma Surgery, Cognitive Deficits | Phase 1 | Status: UNKNOWN